multiplicity of infection
[용어속성] Term
A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human Subjects
인간 기도 상피 세포에서 SARS-CoV-2 복제를 제거하는 치료법은 건강한 인간 대상에서 에어로졸로 흡입하기에 안전합니다
Article
[키워드] Activation
aerosol
airway
Airway inflammation
airway pH.
Cell
cells
clinical trial
Concentration
COVID-19
Defense
determine
Diseases
endosomal trafficking
expression
had no
healthy subjects
Host
host defense
Human
human airway epithelial
humans
impair
in vivo
Infection
inhalation
Inhaled
inhibited
isotonicity
Lung function
mechanisms
multiplicity
multiplicity of infection
N protein
no effect
nucleocapsid
osmolality
Oxygenation
Patient
patient safety
phase
Placebo
Plaque assay
Prevent
prevented
protein levels
raise
raised
Replication
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 viral replication
subject
subjects
Treatment
Trial
USA-WA1/2020
viability
Viral
viral infection
viral replication
vital signs
was determined
[DOI] 10.4187/respcare.08425 PMC 바로가기 [Article Type] Article
[DOI] 10.4187/respcare.08425 PMC 바로가기 [Article Type] Article
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
Research article
[키워드] activities
acute lung injury
administration
analysis of variance
ANOVAanalysis of variance
average steady-state plasma concentration
baicalein
BALFbronchoalveolar lavage fluid
Body weight loss
Bronchoalveolar lavage fluid
Cavgaverage steady-state plasma concentration
CC50half-cytotoxic concentration
cell damage
Cmaxpeak plasma concentration
Concentration
Coronavirus disease 2019
COVID-19
COVID-19coronavirus disease 2019
CPEcytopathic effect
Cytopathic effect
dengue virus
DENVdengue virus
EC50half-maximal effective concentrations
EEPend-expiratory pause
effective
Effects
end-expiratory pause
enhanced pause
H & EHematoxylin and eosin
hACE2
hACE2human angiotensin-converting enzyme 2
half-cytotoxic concentration
half-maximal effective concentrations
Hematoxylin and eosin
HIVhuman immunodeficiency virus
Human angiotensin-converting enzyme 2
Human immunodeficiency virus
IL-1β
in vitro
in vivo
infected with SARS-CoV-2
inflammatory cell infiltration
inhibit
inhibited
Injury
Japanese encephalitis virus
JEVJapanese encephalitis virus
lesion
LLOQLower Limit of Quantitation
Lower Limit of Quantitation
lung
lung tissue
main protease
mice
MOImultiplicity of infection
morphology
Mpromain protease
multiplicity of infection
peak expiratory flow
peak plasma concentration
PEFpeak expiratory flow
Penhenhanced pause
pharmacological
reached
Replication
Respiratory function
Result
SARS-CoV-2
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
Scutellaria baicalensis
selection index
serum
severe acute respiratory syndrome coronavirus 2
significantly
SIselection index
therapeutic drug
therapeutic effect
TNF-α
transgenic mice
Treatment
Vero E6 cell
virus
was performed
Zika virus
ZIKVZika virus
[DOI] 10.1016/j.bcp.2020.114302 [Article Type] Research article
[DOI] 10.1016/j.bcp.2020.114302 [Article Type] Research article
Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces
말라리아 기생충의 분자 감시 및 특정 베트남 지방의 시간적 모니터링
Research
[키워드] malaria
msp1
msp2
multiplicity of infection
species
Vietnam
[DOI] 10.1186/s12936-020-03561-6 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12936-020-03561-6 PMC 바로가기 [Article Type] Research
Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study
라이노바이러스와 인플루엔자 A 바이러스의 간섭: 임상 데이터 분석 및 실험적 감염 연구
Article
[키워드] 95% CI
Affect
airway
Analysis
Antiviral
blocking
Cell culture
cell cultures
Clinical data
co-occurrence
Course
COVID-19 pandemic
Culture
decrease
Department
Epidemic
Epidemics
epithelial
Europe
European country
examination
expected
expression
finding
fluorescent
Frame
funding
GFP
green fluorescent protein
H1N1
H1N1pdm09
host cell
IAV
idea
inclusion criteria
indicated
Infection
Influenza
influenza A
influenza A virus
inhibit
inoculated
Interference
interferon
interferon response
interferon-stimulated gene
interferon-stimulated genes
Intervention
ISG
ISGs
medical record
Medical Sciences
Medicine
Microscopy
mock infection
MOI
mRNA
mucosa
Multiplex PCR
multiplicity
multiplicity of infection
Odds ratio
pandemic
positive
Post-infection
primary human airway
Protein
quantitative PCR
Replication
reporter
respiratory
respiratory sample
Respiratory samples
respiratory specimen
respiratory specimens
respiratory virus
restored
resulting
reverse transcription
Reverse transcription quantitative PCR
rhinovirus
RNA
Seasonal influenza
significantly lower
Spread
Stimulation
subsequent
System
tested
the interferon
Time frame
USA
Viral
Viral RNA
virus
was used
[DOI] 10.1016/s2666-5247(20)30114-2 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/s2666-5247(20)30114-2 PMC 바로가기 [Article Type] Article
Concentration of infectious SARS-CoV-2 by polyethylene glycol precipitation
Short Communication
[키워드] acute respiratory syndrome
applied
assays
Caco-2
Caco-2 cells
Calu-3
Concentration
coronavirus
COVID-19
glycol
human cell line
immortalized
increase in
Infection
log
medical countermeasure
methodology
multiplicity of infection
PEG precipitation
Polyethylene glycol
protocol
provide
Research
resource
robust
SARS-CoV-2
supernatant
titre
ultracentrifugation
utility
VeroE6 cell
virus
virus concentration
virus stock
[DOI] 10.1016/j.jviromet.2020.113977 PMC 바로가기 [Article Type] Short Communication
[DOI] 10.1016/j.jviromet.2020.113977 PMC 바로가기 [Article Type] Short Communication
Genetic diversity and complexity of Plasmodium falciparum infections in the microenvironment among siblings of the same household in North-Central Nigeria
북중부 나이지리아의 같은 가정 내 형제들 사이에서의 플라스모디움 팔시파룸 감염의 유전적 다양성과 복잡성
Research
[키워드] genetic diversity
malaria
Micro-environment
MSP-2
multiplicity of infection
Nigeria
Plasmodium falciparum
Transmission intensity
[DOI] 10.1186/s12936-020-03415-1 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12936-020-03415-1 PMC 바로가기 [Article Type] Research
Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
부르키나파소에서의 플라스모디움 팔시파룸 감염 다중성 및 유전적 다양성의 결정 요인
Research
[키워드] malaria
msp1
msp2
multiplicity of infection
Plasmodium falciparum
[DOI] 10.1186/s13071-020-04302-z PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13071-020-04302-z PMC 바로가기 [Article Type] Research
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Review article
[키워드] ACE2angiotensin-converting enzyme 2
acute respiratory distress syndrome
acute respiratory syndrome
angiotensin-converting enzyme 2
animal models
annexinA5
Anti-inflammatory
anti-malarial drug
Anti-phospholipid
anti-phospholipid syndrome
anti-thrombotic properties
Anti-viral
anti-viral effect
antigen-presenting cell
AnxA5annexinA5
APCantigen-presenting cell
aPLanti-phospholipid
APSanti-phospholipid syndrome
ARDSacute respiratory distress syndrome
Autoimmune disease
BMP/SMADbone morphogenetic/small mother against decapentaplegic
bone morphogenetic/small mother against decapentaplegic
caused
Cell culture
Chloroquine
chloroquine/hydroxychloroquine
chronic obstructive pulmonary disease
Clathrin-mediated endocytosis
Clinical course
Clinical efficacy
Clinical improvement
CMEclathrin-mediated endocytosis
COPDchronic obstructive pulmonary disease
coronavirus
coronavirus disease
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19Sars-Cov-2 infection
CQChloroquine
DCdendritic cell
dendritic cell
disease
divalent metal-ion transporter 1
DMT1divalent metal-ion transporter 1
drug
early endosome
EEearly endosome
Effects
Efficacy
Endoplasmic reticulum
endoplasmic reticulum-Golgi intermediate compartment
endosomal NADPH oxidase
endothelial nitric oxide synthetase
eNOSendothelial nitric oxide synthetase
eNOXendosomal NADPH oxidase
EPOerythropoietin
ERendoplasmic reticulum
ERFEerythroferrone
ERGICendoplasmic reticulum-Golgi intermediate compartment
erythroferrone
erythropoietin
experimental evidence
ferritin
ferroportin 1
FPN1ferroportin 1
FTferritin
HAEChuman aortic endotelial cell
HAMPhepcidin
haptoglobin
HCMVHuman Cytomegalovirus
HCQ
HCQhydroxychloroquine
HCVHepatitis C virus
hemochromatosis
hemochromatosis gene
hemopexin
hepatitis C virus
hepcidin
HFEhemochromatosis gene
HHhemochromatosis
HIV-1Human Deficiency Virus 1
HPhaptoglobin
HPXhemopexin
human aortic endotelial cell
Human Cytomegalovirus
Human Deficiency Virus 1
human umbilical vein endothelial cell
HUVEChuman umbilical vein endothelial cell
Hydroxychloroquine
ICUIntensive Care Unit
IDAiron deficiency anemia
IDiron deficiency
IDUinfectious disease unit
IFN-γinterferon-γ
IFN1type interferon
IgGimmunoglobulin G
IL-12interleukin-12
IL-13interleukin-13
IL-17interleukin-17
IL-1βinterleukin-1β
IL-4interleukin-4
IL-6interleukin-6
Immunoglobulin G
immunomodulatory
Infection
infectious disease unit
intensive care unit
interferon-γ
interleukin-12
interleukin-13
interleukin-17
interleukin-1β
Interleukin-4
interleukin-6
iron deficiency
iron deficiency anemia
iron homeostasis
JAK/STAT3Janus kinase/signal transducers and activators of transcription 3
Janus kinase/signal transducers and activators of transcription 3
knowledge
lactoferrin
late endosome-lysosome
LELlate endosome-lysosome
less
LFlactoferrin
lipopolysaccharide
LPSlipopolysaccharide
mAbMonoclonal antibody
major histocompatibility complex
MAPKmitogen-activated protein kinase
matrix metalloproteinase
mechanism
metalloreductase six-transmembrane epithelial antigen of the prostate 3
MHCMajor Histocompatibility Complex
MHV-3mouse hepatitis virus type 3
mitogen-activated protein kinase
MMPmatrix metalloproteinase
MOImultiplicity of infection
monoclonal antibody
mouse hepatitis virus type 3
mucolipin 1
multiplicity of infection
Mviral envelope membrane protein
NADPH oxidase 2
natural killer
NETneutrophil extracellular trap
Neutrophil extracellular trap
NKnatural killer
NOX2NADPH oxidase 2
NPvirus nucleoprotein
pandemic
Patient
pharmacological
phosphatidylinositol binding clathrin assembly protein
PICALMphosphatidylinositol binding clathrin assembly protein
potential mechanism
Randomized controlled studies
RArheumatoid arthritis
RBCred blood cell
red blood cell
regimen
rheumatoid arthritis
SARS-COV-2 infection
severity
SLEsystemic lupus erythematosus (SLE)
STEAP3metalloreductase six-transmembrane epithelial antigen of the prostate 3
Sviral spike protein
systemic lupus erythematosus (SLE)
T helper
TFR1transferrin receptor 1
TFtissue factor
TGNtrans-Golgi network
TGTthrombin generating time
therapeutic
thrombin generating time
ThT helper
Tissue Factor
TLRToll-like receptor
TMPRSS2transmembrane serine protease 2
TNF-αtumor necrosis factor-α
Toll-like receptor
trans-Golgi network
transferrin receptor 1
transmembrane serine protease 2
treat
Treatment
TRPML1/MCOLN1mucolipin 1
tumor necrosis factor-α
type interferon
vascular cellular adhesion molecule 1
VCAM-1vascular cellular adhesion molecule 1
viral envelope membrane protein
viral infections
viral spike protein
virus nucleoprotein
β2-glicoprotein I
β2GPIβ2-glicoprotein I
[DOI] 10.1016/j.phrs.2020.104904 [Article Type] Review article
[DOI] 10.1016/j.phrs.2020.104904 [Article Type] Review article
Quantitative Proteomic Analysis Reveals Antiviral and Anti-inflammatory Effects of Puerarin in Piglets Infected With Porcine Epidemic Diarrhea Virus
Immunology
[키워드] activities
addition
Administered
African green monkey
analyses
Analysis
Anti-inflammatory
anti-inflammatory effect
Anti-viral
Antiviral
assigned
Blood
caused
Cell
cell proliferation
Chinese
collected
conducted
Control
control group
control level
Culture
cytokine
determine
Effect
effective
epidemic diarrhea
expression
group
growth
IL-8
in vitro
in vivo
Infection
infectious dose
inhibited
interferon-stimulated gene
intestinal
kidney
mechanism
multiplicity of infection
Neonatal
NF-κB activation
PEDV
pharmacological
Piglets
Porcine epidemic diarrhea virus
Protein
Proteins
proteomic
proteomics
puerarin
Randomly
reductions in
Replication
restored
serum-free DMEM
sterile saline
TCID
three group
tissue
treated
Trial
two group
upregulated
Vero
Vero Cell
virus
Volume
were infected
Western blot analysis
[DOI] 10.3389/fimmu.2020.00169 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.00169 PMC 바로가기 [Article Type] Immunology